2016 Annual Meeting | Myelopathies II

Date Sunday 04/17/16

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Benjamin M. Greenberg, MD, FAAN

Topic(s)

Learning Objectives Participants should be able to formulate management plans for patients relative to their neuropathic pain, rehabilitation needs, bladder management, bowel management, and sexual dysfunction.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
03:30 PM - 03:35 PM		Introduction Benjamin M. Greenberg, MD, FAAN
03:35 PM - 04:05 PM		Managing Neuropathic Pain in Myelopathy Patients Allen D. DeSena, MD
04:05 PM - 04:10 PM		Questions and Answers Allen D. DeSena, MD
04:10 PM - 04:40 PM		Evaluating and Treating Gait Dysfunction in Myelopathy Patients Karen McCain, DPT
04:40 PM - 04:45 PM		Questions and Answers Karen McCain, DPT
04:45 PM - 05:15 PM		Managing Neurogenic Bowel and Bladder in Myelopathy Patients Anthony Burns, MD
05:15 PM - 05:20 PM		Questions and Answers Anthony Burns, MD
05:20 PM - 05:30 PM		Questions and Answers Anthony Burns, MD, Allen D. DeSena, MD, Benjamin M. Greenberg, MD, FAAN, Karen McCain, DPT

Faculty Disclosures
Allen D. DeSena, MD	No disclosure on file
Benjamin M. Greenberg, MD, FAAN	Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Husch Blackwell. Dr. Greenberg has stock in GenrAb. Dr. Greenberg has stock in Clene. The institution of Dr. Greenberg has received research support from Anokion. The institution of Dr. Greenberg has received research support from Regeneron. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.
Karen McCain, DPT	No disclosure on file
Anthony Burns, MD	No disclosure on file

��ɫ��

��ɫ��